215 related articles for article (PubMed ID: 15766029)
1. [Lowering blood pressure with new calcium antagonists. High benefit by innovative mechanism of action].
MMW Fortschr Med; 2005 Feb; 147(5):46-7. PubMed ID: 15766029
[No Abstract] [Full Text] [Related]
2. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
3. [Most hypertensive patients need drug combination treatment. "First line therapy is in second place"].
MMW Fortschr Med; 2003 Aug; 145(33-34):61. PubMed ID: 14526585
[No Abstract] [Full Text] [Related]
4. [Depot calcium antagonist. General practice study confirms good tolerance].
MMW Fortschr Med; 2003 Jan; 145(5):56. PubMed ID: 12619222
[No Abstract] [Full Text] [Related]
5. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
6. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
Chatzikyrkou C; Haller H; Menne J
Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
[TBL] [Abstract][Full Text] [Related]
7. [Also for problem cases; successful first line therapy].
MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
[No Abstract] [Full Text] [Related]
8. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
Bühler G; Wadepuhl M; Nandi K; Rosenthal J
Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
[No Abstract] [Full Text] [Related]
9. [Therapy of hypertension is mostly combination therapy. Calcium antagonists are ideal partners].
MMW Fortschr Med; 2003 Jun; 145(26):60. PubMed ID: 12916344
[No Abstract] [Full Text] [Related]
10. Antihypertensive and humoral effects of verapamil and lacidipine in combination in hypertensive patients.
Comerio G; Cuspidi C; Bocciolone M; Lonati L; Sampieri L; Boselli L; Leonetti G; Zanchetti A
J Hypertens Suppl; 1993 Dec; 11(5):S336-7. PubMed ID: 8158411
[No Abstract] [Full Text] [Related]
11. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
[No Abstract] [Full Text] [Related]
12. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 3: Safety, efficacy, tolerability and duration of action.
Meredith PA
J Hypertens Suppl; 1993 Dec; 11(6):S33-5. PubMed ID: 8169381
[No Abstract] [Full Text] [Related]
13. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists in treatment of hypertension. Proper selection and drug combinations if needed].
Trenkwalder P
MMW Fortschr Med; 2001 May; 143(22):27-8. PubMed ID: 11460394
[No Abstract] [Full Text] [Related]
15. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Christensen KL
Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
[No Abstract] [Full Text] [Related]
16. Selection of initial and maintenance dosages for lacidipine, a new once-daily calcium antagonist for the treatment of hypertension.
Perelman M
J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S14-8; discussion S18-9. PubMed ID: 1726000
[TBL] [Abstract][Full Text] [Related]
17. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
18. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
[No Abstract] [Full Text] [Related]
19. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic considerations in the elderly hypertensive. The role of calcium channel blockers.
Black HR
Am J Hypertens; 1990 Dec; 3(12 Pt 2):347S-354S. PubMed ID: 2078322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
